Purpose: To investigate [18F]-fluoromisonidazole positron emission tomography/computed tomography (FMISO-PET/CT) detection of targetable hypoxic subvolumes (HSVs) in chordoma of the mobile or sacrococcygeal spine.
Methods And Materials: A prospective, pilot study of 20 patients with primary or locally recurrent chordoma of the mobile or sacrococcygeal spine treated with proton or combined proton/photon radiation therapy (RT) with or without surgery was completed. The FMISO-PET/CT was performed before RT and after 19.8-34.2 GyRBE (relative biologic effectiveness). Gross tumor volumes were delineated and HSVs defined including voxels with standardized uptake values ≥1.4 times the muscle mean. Clinical characteristics and treatments received were compared between patients with and without HSVs.
Results: The FMISO-PET/CT detected HSVs in 12 of 20 patients (60%). Baseline and interval HSV spatial concordance varied (0%-94%). Eight HSVs were sufficiently large (≥5 cm(3)) to potentially allow an intensity modulated proton therapy boost. Patients with HSVs had significantly larger gross tumor volumes (median 410.0 cm(3) vs 63.4 cm(3); P=.02) and were significantly more likely to have stage T2 tumors (5 of 12 vs 0 of 8; P=.04). After a median follow-up of 1.8 years (range, 0.2-4.4 years), a local recurrence has yet to be observed. Three patients developed metastatic disease, 2 with HSVs.
Conclusions: Detection of targetable HSVs by FMISO-PET/CT within patients undergoing RT with or without surgery for treatment of chordoma of the mobile and sacrococcygeal spine is feasible. The study's inability to attribute interval HSV changes to treatment, rapidly changing hypoxic physiology, or imaging inconsistencies is a limitation. Further study of double-baseline FMISO-PET/CT and hypoxia-directed RT dose escalation, particularly in patients at high risk for local recurrence, is warranted.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280072 | PMC |
| http://dx.doi.org/10.1016/j.ijrobp.2014.08.016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characteristics and survival outcomes in pediatric patients with spinal chordomas: insights from the National Cancer Database and review of the literature.
J Neurooncol
January 2025
Departments of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Purpose: Spinal chordomas are aggressive tumors that rarely occur in the pediatric population. Demographics and post-treatment outcomes in this select group of patients is poorly studied. We hence aimed to analyze the clinical characteristics, demographics, and survival outcomes of pediatric patients with spinal chordomas, in contrast to the adult population.
View Article and Find Full Text PDFChordoma incidence, treatment, and survival in the 21st century: a population-based Ontario cohort study.
J Neurosurg
October 2024
1Department of Surgery, Division of Neurosurgery, University of Toronto, Ontario, Canada.
Article Synopsis
- This study analyzes the incidence, treatment methods, and overall survival rates for chordoma patients in Ontario over 17 years (2003-2019), using data from the Ontario Cancer Registry.
- A total of 208 patients were diagnosed, with treatment trends showing an increase in radiation and chemotherapy use, while open surgery decreased, particularly for mobile spine cases.
- Overall survival probabilities at 5, 10, and 15 years post-diagnosis were 74%, 58%, and 48%, respectively, with no significant link found between survival and diagnosis year or tumor location.
Therapeutic strategies for mobile spine chordoma: en bloc Versus intralesional surgery with adjuvant charged-particle therapy.
J Neurooncol
January 2025
Department of Spine Surgery, IRCCS Istituto Ortopedico Rizzoli, via G.C. Pupilli, 1, Bologna, 40136, Italy.
Article Synopsis
- The study compares the effectiveness of two surgical approaches for treating mobile spine chordomas: en bloc resection versus intralesional resection with adjuvant hadron therapy, focusing on local control (LC) and overall survival (OS).
- In the analysis of 33 patients, no significant differences in LC between the two methods were found, but certain pre-operative factors like pathologic fractures were linked to a higher risk of local recurrence (LR).
- Although en bloc resection is preferred for better outcomes, advances in hadron therapy provide a viable alternative for local control with manageable side effects when using intralesional surgery.
Impact of Dosimetric Compromises on Early Outcomes of Chordomas and Chondrosarcomas Treated With Image-guided Pencil Beam Scanning Proton Beam Therapy.
Adv Radiat Oncol
October 2024
Department of Radiation Oncology, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India.
Purpose: To critically review the clinical factors, dosimetry, and their correlation with early outcomes in patients with chordomas and chondrosarcomas treated with pencil beam scanning (PBS) proton beam therapy (PBT).
Methods And Materials: Consecutive 64 patients diagnosed with chordoma or chondrosarcoma treated at our center were studied. Patient, tumor, and treatment-related factors including dosimetry were captured.
Conventional Spinal Chordomas: Investigation of SMARCB1/INI1 Protein Expression, Genetic Alterations in Gene, and Clinicopathological Features in 89 Patients.
Cancers (Basel)
August 2024
Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Article Synopsis
- Recent studies show a partial loss of SMARCB1/INI1 expression in skull base chordomas, suggesting potential treatment options for these tumors; this study focused on 89 patients with spinal chordomas.
- The analysis found that 41.6% of patients exhibited partial SMARCB1/INI1 loss, primarily due to a deletion on chromosome 22, with significant implications for tumor location and surgical outcomes.
- Key findings indicated that tumor location (specifically in the sacrococcygeal region) and adequate surgical margins were linked to better disease-free survival rates, highlighting important factors for patient prognosis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!